Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 24 filings.
25 Sept 2026 1 filing
Resigning director details
Name and designation: Rahul Dilip Shah, Director (DIN: 01545609).
Cessation date: September 24, 2026.
Reason: Change in management/control via Open Offer by Harmony Remedies; director based in USA.
Immediate effect: Resignation tendered with immediate effect.
Confirmation: Reasons confirmed as stated in resignation letter.
22 Sept 2026 1 filing
AGM extension and control change
ROC has granted time until December 31, 2026 to convene the FY 2025-26 AGM.
There is change in control and management following an open offer by Harmony Remedies Private Limited and PAC.
13 Aug 2026 2 filings
Resignation details
Trupti Pandit - Director and Chief Executive Officer (CEO).
Directorship type: Executive director.
Effective resignation date: 13 August 2026.
Reason for resignation: Change in management and control after the Open Offer.
Material reasons: No other material reasons beyond those stated.
Roles affected: Vacates Director and CEO positions; no other board/committee memberships specified.
Regulatory or shareholder approvals: not stated as required.
Consequence on board: No changes to board composition disclosed.
Resigning director details
Name and designation: Mr. Tushar Shah, Director and CFO.
Effective date of resignation: August 13, 2026.
Reason: resignation due to change in management and control following the Open Offer.
Letter of resignation: dated August 13, 2026.
Material reasons: no other material reasons beyond those stated.
Consequence: resignation from Director and CFO positions.
Board action: Board accepted resignation with effect from August 13, 2026.
Regulatory/ shareholder approvals: not stated as required.
12 Aug 2026 4 filings
No brief for this announcement. This type of announcement aren’t summarised. View the original using the link below
New Additional Directors
Nariman Karbhari appointed Additional Director, Chairman and Non-Executive Director, effective Aug 12, 2026; due to Open Offer.
Mehul J. Parekh appointed Additional Director and Executive Director, effective Aug 12, 2026; due to Open Offer.
Firoze N. Kapadia appointed Additional Director and Executive Director, effective Aug 12, 2026; due to Open Offer.
Animesh Tapiawala appointed Additional Director and Non-Executive Director, effective Aug 12, 2026; due to Open Offer.
Not debarred from holding director office by SEBI or statutory authorities.
Change in control & promoters
Open Offer completed; control vested in Harmony Remedies India Pvt Ltd and PACs, effective Aug 13, 2026.
Rahul Dilip Shah reclassified to Public; Rekha Rani Sarawgi ceases as promoter.
PAC1 and PAC2 are Representing Directors of the Acquirer and acting in concert.
Acquirer/PACs were not related parties prior to change.
Board reconstitution initiated; detailed changes to be disclosed separately.
Company to cease IT & Software consulting post-change.
Regulatory & timeline
Change effected on August 13, 2026 following Open Offer completion.
Open Offer under SEBI Regulations triggered change in management and control.
Promoter shareholding classification: Rahul Shah moved from Promoter to Public.
Rekha Rani Sarawgi ceased as promoter.
Q1 FY2026: Standalone results
Revenue from operations: Rs 15.20 Lacs in Q1 FY2026.
Employee benefits expense: Rs 22.30 Lacs.
Depreciation and amortisation: Rs 1.61 Lacs.
Total expenses: Rs 27.69 Lacs.
Profit before tax: Rs (12.49) Lacs.
Net profit for the period: Rs (12.49) Lacs.
Basic & Diluted EPS: Rs (0.39).
Auditors' Limited Review with unmodified opinion.
Single segment: Tech Support Services; segment reporting not applicable.
6 Aug 2026 1 filing
Meeting Details
Board meeting on August 12, 2026 to consider unaudited standalone results for the quarter ended June 30, 2026.
Key Agenda Items
Unaudited standalone financial results for the quarter ended June 30, 2026, with limited review report.
Change of Management and Control of the Company.
Change of Promoters pursuant to change of management and control in view of Open Offer.
Appointment of Directors pursuant to change of management and control in view of Open Offer.
Other Notes
Trading window closed for two trading days from the date of declaration of financial results.
30 Jul 2026 1 filing
Dematerialisation status
Dematerialisation requests were confirmed (accepted/rejected) to depositories.
Dematerialised securities have been listed on the stock exchanges.
Physical certificates for dematerialisation were mutilated and cancelled; ownership updated in the records.